Cargando…
Cardioembolic stroke: everything has changed
Historically, because of the difficulty of using warfarin safely and effectively, many patients with cardioembolic stroke who should have been anticoagulated were instead given ineffective antiplatelet therapy (or no antithrombotic therapy). With the arrival of new oral anticoagulants that are not s...
Autor principal: | Spence, J David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047338/ https://www.ncbi.nlm.nih.gov/pubmed/30022801 http://dx.doi.org/10.1136/svn-2018-000143 |
Ejemplares similares
-
Updates on Prevention of Cardioembolic Strokes
por: Topcuoglu, Mehmet Akif, et al.
Publicado: (2018) -
Antithrombotic Medication for Cardioembolic Stroke Prevention
por: Font, M. Àngels, et al.
Publicado: (2011) -
Blood Biomarkers in Cardioembolic Stroke
por: García-Berrocoso, Teresa, et al.
Publicado: (2010) -
Echocardiography in cardioembolic stroke prevention
por: Canali, Emanuele, et al.
Publicado: (2023) -
Cardioembolic stroke: An update on etiology, diagnosis and management
por: Leary, Megan C., et al.
Publicado: (2008)